AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)
AbCellera Biologics' (ABCL) quarterly Debt Ratio came in at 0.01 in Q1 2025, down 81.44% YoY from 0.04 in Q1 2024, and up 9.78% on a QoQ basis from 0.01 in Q4 2024.
AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025) Analysis & Trends
AbCellera Biologics (ABCL) has 6 years of Debt Ratio data on file, last reported at 0.01 in Q1 2025.
- Quarterly Debt Ratio fell 81.44% year-over-year to 0.01 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.01 (down 81.44% YoY) and the FY2024 annual result came in at 0.01, down 82.48% from the prior year.
- Debt Ratio rose to 0.01 in Q1 2025, from 0.01 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.04 in Q2 2023 to a low of 0.01 in Q4 2024.
- A 5-year average of 0.02 and a median of 0.02 in 2021 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio surged 113.92% — and 2024, when it slumped 82.48%.
- Tracing ABCL's Debt Ratio over 5 years: stood at 0.02 in 2021, then jumped by 64.96% to 0.03 in 2022, then rose by 18.22% to 0.03 in 2023, then slumped by 82.48% to 0.01 in 2024, then climbed by 9.78% to 0.01 in 2025.
- The last three Debt Ratio figures came in at 0.01 (Q1 2025), 0.01 (Q4 2024), and 0.01 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.01 |